Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.

× No keyword cloud information.

11 in total

1. [New antibiotics for severe infections due to multidrug-resistant pathogens : Definitive treatment and escalation].

Authors: D C Richter; T Brenner; A Brinkmann; B Grabein; M Hochreiter; A Heininger; D Störzinger; J Briegel; M Pletz; M A Weigand; C Lichtenstern
Journal: Anaesthesist Date: 2019-11 Impact factor: 1.041

Review 2. Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.

Authors: Sanjiv M Baxi; Dominic Chan; Vivek Jain
Journal: Infection Date: 2015-03-25 Impact factor: 3.553

3. Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.

Authors: Kimberly C Claeys; Jordan R Smith; Anthony M Casapao; Ryan P Mynatt; Lisa Avery; Anjali Shroff; Deborah Yamamura; Susan L Davis; Michael J Rybak
Journal: Antimicrob Agents Chemother Date: 2015-01-20 Impact factor: 5.191

Review 4. Bacterial sepsis : Diagnostics and calculated antibiotic therapy.

Authors: D C Richter; A Heininger; T Brenner; M Hochreiter; M Bernhard; J Briegel; S Dubler; B Grabein; A Hecker; W A Kruger; K Mayer; M W Pletz; D Storzinger; N Pinder; T Hoppe-Tichy; S Weiterer; S Zimmermann; A Brinkmann; M A Weigand; C Lichtenstern
Journal: Anaesthesist Date: 2019-02 Impact factor: 1.041

5. Management of MRSA/GISA, VISA Endocarditis.

Authors: Cédric Jacqueline; Jocelyne Caillon; David Boutoille
Journal: Curr Infect Dis Rep Date: 2013-08 Impact factor: 3.725

Review 6. [Bacterial sepsis : Diagnostics and calculated antibiotic therapy].

Authors: D C Richter; A Heininger; T Brenner; M Hochreiter; M Bernhard; J Briegel; S Dubler; B Grabein; A Hecker; W A Krüger; K Mayer; M W Pletz; D Störzinger; N Pinder; T Hoppe-Tichy; S Weiterer; S Zimmermann; A Brinkmann; M A Weigand; Christoph Lichtenstern
Journal: Anaesthesist Date: 2017-10 Impact factor: 1.041

7. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.

Authors: Brian J Werth; Katie E Barber; Cortney E Ireland; Michael J Rybak
Journal: Antimicrob Agents Chemother Date: 2014-03-24 Impact factor: 5.191

Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.